Trial intelligence / Profile preview

A+C meningococcal polysaccharide vaccine in healthy subjects aged 2–55 years

CTR20140069Phase 3Completed

Sponsor
Wuhan Institute of Biological Products
Start
Mar 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal polysaccharide vaccine, groups A and C in meningococcal disease, meningococcal meningitis, sponsored by Wuhan Institute of Biological Products. Started Mar 2014; status: completed.

02

Drugs

meningococcal polysaccharide vaccine, groups A and C
03

Conditions

meningococcal diseasemeningococcal meningitis

Beyond the preview

Go deeper on CTR20140069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call